References
- Elias K E, Weiner R I. Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci U.S.A 1984; 81: 4549–4553
- Inoue K, Hattori M, Sakai T, Inukai S, Fujimoto N, Ito A. Establishment of a series of pituitary clonal cell lines differing in morphology, hormone secretion, and response to estrogen. Endocrinology 1990; 126: 2313–2320
- Song J, Jin L, Lloyd R V. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells. Cancer Res 1989; 49: 1247–1253
- Zhang K, Kulig, Jin L, Lloyd R V. Effects of estrogen and epidermal growth factor on prolactin and Pit-1 mRNA in GH3 cells. Proc Soc Exp Biol Med 1993; 202: 193–200
- Inoue K, Matsumoto H, Koyama C, Shibata K, Nakazawa Y, Ito A. Establishment of a folliculo-stellate-like cell line from a murine thyrotropic pituitary tumor. Endocrinology 1992; 131: 3110–3116
- Li F, Koga M, Kasayama S, Matsumoto K, Arita N, Hayakawa T, Sato B. Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. J Clin Endocrinol Metab 1992; 75: 1436–1441
- Gospodarowicz D, Neufeld G, Schweigerer L. Molecular and biological characterization of fibroblast growth factor an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell Differentiation 1986; 19: 1–17
- Liod R V. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland: an immunohistochemical study. Am J Pathol 1983; 113: 198–206
- Ahmed S D, Gogal R M, Jr, Walsh J E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to H3-thymidine incorporation assay. J Immunol Methods 1994; 170: 211–224
- Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
- Ito A, Kawashima K, Fujimoto N, Watanabe H, Naito M. Inhibition by 2-bromo-o-ergocriptine and tamoxifen of the growth of an estrogen-induced transplantable pituitary tumor (MtT/F84) in F344 rats. Cancer Res 1985; 45: 6436–6441
- Lingham R L, Stancel G M, Loose-Mitchell D S. Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. Mol Endocrinol 1988; 232: 230–235
- Sumner BE H, Fink G. Estrogen increases the density of 5-hydroxy-tryptamine2A receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol 1995; 54: 15–20
- McLeskey S W, Ding IY F, Lippman M E, Kern F G. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor(FGF) receptors and are growth-inhibited by FGF ligands. Cancer Res 1994; 54: 523–530
- Prysor-Jones P A, Silverlight J J, Jenkins J S. Oestradiol vasoactive intestinal peptide and fibroblast growth factor in the growth of human pituitary tumour cells in vitro. J Endocrinology 1988; 120: 171–177